Skip to main content
. 2019 Feb 10;34(5):284–294. doi: 10.1177/0883073819827407

Figure 3.

Figure 3.

Relationship between model-predicted Cav,ss of perampanel dose normalized to 8 mg and age (A) and weight (B) stratified by concomitant use of EIAEDs and non-EIAEDs. The red line is loess smooth. (Cav,ss, steady-state average concentration during a dosing interval; EIAED, enzyme-inducing antiepileptic drug.)